期刊文献+

前列腺癌15例治疗回顾

Retrospective Treatment of 15 Patients with Prostate Cancer
下载PDF
导出
摘要 目的:探讨基层医院前列腺癌的诊断与治疗。方法:分析15例前列腺癌诊疗过程临床资料。结果:13例患者排尿梗阻及尿道刺激症状明显改善,术后PSA降至正常水平,1例失去随访,1例PSA反复波动正接受放射治疗。结论:基层医院要重视前列腺癌的早期诊断。对高危前列腺癌患者,应按照前列腺癌诊断治疗指南,综合应用内分泌治疗、根治性手术、放射治疗、根治性经尿道前列腺切除等治疗方法。 Objective: To identify the key of the diagnosis and treatment of Prostate cancer in basic level hospital. Method: We performed a retrospective case analysis of 15 patients with Prostate cancer. Results: 13 patients had significant improvements in urinary obstruction and urethral irritation; So far the prostate-specific antigen (PSA) level was back to normal level after surgery, 1 patient was loss of follow- up and 1 patient had unstable PSA level that is under radiation therapy. Conclusion: The basic level hos- pital should pay enough attention to prostate cancer. In accordance with guidelines of the prostate cancer diagnosis and treatment, Combination of endocrine therapy, radical surgery, radical prostatectomy, radio- therapy and radical transurethral resection of the prostate should be applied in high-risk patients with prostate cancer.
出处 《安徽卫生职业技术学院学报》 2009年第3期53-54,共2页 Journal of Anhui Health Vocational & Technical College
关键词 前列腺癌 诊断 治疗 Prostate cancer Diagnosis Treatment
  • 相关文献

参考文献5

二级参考文献98

  • 1Robert J McKenna,Ward Houck,罗晓阳.胸腔镜肺叶切除术[J].中国癌症杂志,2006,16(8):626-630. 被引量:20
  • 2ToshihiroSaito,YasuoKitamura,ShuichiKomatsubara,YasuoMatsumoto,TadashiSugita,Noboru Hara.Outcomes of locally advanced prostate cancer:a single institution study of 209 patients in Japan[J].Asian Journal of Andrology,2006,8(5):555-561. 被引量:8
  • 3Hudes G R,Obasaju C,Chapman A,et al.Phase Ⅰ study of paclitaxel and estramustine:preliminary activity in hormone-refractory prostate cancer[J].Semin Oncol,1995,22:6-11.
  • 4Hudes G R,Nathan F,Khater C,et al.Phase Ⅱ trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer[J].J Clin Oncol,1997,15:3156-3163.
  • 5Vaishampayan U,Fontana J,Du W,et al.An active regimen of weekly paclitaxel and estramustine in metastatic androgen-independent prostate cancer[J].Urology,2002,60:1050-1054.
  • 6Kantoff P W,Halabi S,Conaway M,et al.Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer:results of the cancer and leukemia group B 9182 study[J].J Clin Oncol,1999,17:2506-2513.
  • 7Tannock I F,Osoba D,Stockler M R,et al.Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer:a canadian randomized trial with palliative end points[J].J Clin Oncol,1996,14:1756-1764.
  • 8Beer T M,Pierce W C,Lowe B A,et al.Phase Ⅱ study of weekly docetaxel in symptomatic androgen-independent prostate cancer[J].Ann Oncol,2001,12:1273-1279.
  • 9Picus J,Schultz M.Docetaxel (Taxotere) as monotherapy in the treatmentof hormone-refractory prostate cancer:preliminary results[J].Semin Oncol,1999,26(5 Suppl 17):14-18.
  • 10Petrylak D P,Tangen C M,Hussain M H,et al.Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostatecancer[J].N EnglJ Med,2004,351:1513-1520.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部